|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 20-F filed Mar 30, 2006. World
Pharmaceutical Market
IMS audited global pharmaceutical sales increased by 7% from
2004 to $602.0 billion in 2005. In 2004, IMS audited global
pharmaceutical sales also increased by 7% over 2003. Biotech
products accounted for 9% of global sales in 2005 and account
for 27% of the active research and development pipeline.
North America, Japan and Europe accounted for approximately 82%
of global pharmaceutical sales in 2005, compared to 88% as in
2004. North America’s pharmaceutical sales grew 5% to
$265.7 billion, representing 44% of all global
pharmaceutical sales in 2005.
The U.S. market is our most important market. Please refer
to Note 28 to the Consolidated Financial Statements for an
analysis of revenue by geographic region. For this reason, the
factors discussed below, such as “Government
Regulation” and “Product Approval,” place
emphasis on requirements in the United States.
|
| |||||||
